Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores.
De Vincentis A, Tavaglione F, Jamialahmadi O, Picardi A, Antonelli Incalzi R, Valenti L, Romeo S, Vespasiani-Gentilucci U. De Vincentis A, et al. Among authors: tavaglione f. Clin Gastroenterol Hepatol. 2022 Mar;20(3):658-673. doi: 10.1016/j.cgh.2021.05.056. Epub 2021 Jun 4. Clin Gastroenterol Hepatol. 2022. PMID: 34091049 Free article.
Reply.
De Vincentis A, Tavaglione F, Romeo S, Vespasiani-Gentilucci U. De Vincentis A, et al. Among authors: tavaglione f. Clin Gastroenterol Hepatol. 2022 Nov;20(11):2660-2661. doi: 10.1016/j.cgh.2022.01.010. Epub 2022 Jan 13. Clin Gastroenterol Hepatol. 2022. PMID: 35032632 No abstract available.
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease.
Pennisi G, Pipitone RM, Enea M, De Vincentis A, Battaglia S, Di Marco V, Di Martino V, Spatola F, Tavaglione F, Vespasiani-Gentilucci U, Zito R, Romeo S, Cammà C, Craxì A, Grimaudo S, Petta S. Pennisi G, et al. Among authors: tavaglione f. Hepatol Commun. 2022 May;6(5):1032-1044. doi: 10.1002/hep4.1877. Epub 2022 Feb 11. Hepatol Commun. 2022. PMID: 35146945 Free PMC article.
Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
Baselli GA, Jamialahmadi O, Pelusi S, Ciociola E, Malvestiti F, Saracino M, Santoro L, Cherubini A, Dongiovanni P, Maggioni M, Bianco C, Tavaglione F, Cespiati A, Mancina RM, D'Ambrosio R, Vaira V, Petta S, Miele L, Vespasiani-Gentilucci U, Federico A, Pihlajamaki J, Bugianesi E, Fracanzani AL, Reeves HL, Soardo G, Prati D, Romeo S, Valenti LV; EPIDEMIC Study Investigators. Baselli GA, et al. Among authors: tavaglione f. J Hepatol. 2022 Sep;77(3):596-606. doi: 10.1016/j.jhep.2022.03.031. Epub 2022 Apr 9. J Hepatol. 2022. PMID: 35405176 Free article.
Reply.
Tavaglione F, De Vincentis A, Jamialahmadi O, Vespasiani-Gentilucci U, Romeo S. Tavaglione F, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):856-857. doi: 10.1016/j.cgh.2022.06.008. Epub 2022 Jul 12. Clin Gastroenterol Hepatol. 2023. PMID: 35835343 No abstract available.
Genetic variants in the MTHFR are not associated with fatty liver disease.
De Vincentis A, Mancina RM, Pihlajamäki J, Männistö V, Petta S, Dongiovanni P, Fracanzani AL, Valenti L, Tavaglione F, Romeo S, Vespasiani-Gentilucci U. De Vincentis A, et al. Among authors: tavaglione f. Liver Int. 2020 Aug;40(8):1934-1940. doi: 10.1111/liv.14543. Epub 2020 Jun 11. Liver Int. 2020. PMID: 32460399
37 results